Trial Profile
A Single-Blind, Randomized, Dose-Finding Study Versus Fluconazole to Assess the Efficacy and Tolerability of Five Single Doses of Albaconazole in the Treatment of Acute Non-Recurrent Candida Spp Vulvovaginitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Albaconazole (Primary) ; Fluconazole
- Indications Vulvovaginal candidiasis
- Focus Therapeutic Use
- Sponsors Uriach
- 09 Jun 2014 New trial record